123 related articles for article (PubMed ID: 3931562)
1. [Effects of UFT in advanced renal cell cancer].
Koseki K; Akaza H; Kishi H; Umeda T; Isurugi K; Niijima T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2061-4. PubMed ID: 3931562
[TBL] [Abstract][Full Text] [Related]
2. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
[TBL] [Abstract][Full Text] [Related]
3. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
4. Concentration of 5-fluorouracil in renal cells from cancer patients administered a mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Fujita K; Munakata A
Int J Clin Pharmacol Res; 1991; 11(4):171-4. PubMed ID: 1813435
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of UFT in renal cell carcinoma].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):325-30. PubMed ID: 3918508
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effect of UFT in advanced renal cell carcinoma].
Hoshino M; Inoue K; Higaki M; Imamura K
Hinyokika Kiyo; 1988 Mar; 34(3):538-40. PubMed ID: 3133935
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of UFT chemotherapy in renal cancer. Kyushu University Cooperative Study Group of Renal Cancer].
Ueda T; Kumazawa J; Ohmori A; Sakamoto K; Aito K; Morita I; Ohta Y; Takesue T; Hara S; Sagiyama K
Gan To Kagaku Ryoho; 1990 Feb; 17(2):239-43. PubMed ID: 2105698
[TBL] [Abstract][Full Text] [Related]
8. [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Sugawara T; Sakuramoto T; Fukushima S
Hinyokika Kiyo; 1987 Aug; 33(8):1232-5. PubMed ID: 3122543
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Fujioka T; Hasegawa M; Ishikura K; Nomura K; Okamoto T; Tanji S; Koike H; Kubo T
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2031-6. PubMed ID: 2221926
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of UFT in far-advanced renal cell carcinoma].
Matsuyama H; Yamamoto N; Sakatoku J; Hara Y; Sacho T; Yasui H; Ichikawa T; Koshido Y; Hayasida S; Nagata K
Gan To Kagaku Ryoho; 1988 Mar; 15(3):527-30. PubMed ID: 3126711
[No Abstract] [Full Text] [Related]
13. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
15. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Oiwa T; Saito H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of UFT against differentiated thyroid cancer].
Suzumura K; Koike A; Naruse T; Matsumoto K; Nagata H; Kojima T; Kanemitsu T; Katoh K
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2485-9. PubMed ID: 7944495
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Hoshi K; Kanbara T; Kawasaki Y; Ikeda Y; Namima T; Ohnuma T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1315-7. PubMed ID: 17687222
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of renal cell carcinoma].
Yamada Y; Fukatsu H; Honda N; Miyagawa Y; Segawa A
Hinyokika Kiyo; 1993 Dec; 39(12):1197-203. PubMed ID: 7506869
[TBL] [Abstract][Full Text] [Related]
19. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
20. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
Kanno H; Kitami K; Senga Y; Takahashi T; Nagashima Y
Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
